tetraethylammonium has been researched along with Hamartoma in 1 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Hamartoma: A focal malformation resembling a neoplasm, composed of an overgrowth of mature cells and tissues that normally occur in the affected area.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wu, J | 1 |
Xu, L | 1 |
Kim, DY | 1 |
Rho, JM | 1 |
St John, PA | 1 |
Lue, LF | 1 |
Coons, S | 1 |
Ellsworth, K | 1 |
Nowak, L | 1 |
Johnson, E | 1 |
Rekate, H | 1 |
Kerrigan, JF | 1 |
1 other study available for tetraethylammonium and Hamartoma
Article | Year |
---|---|
Electrophysiological properties of human hypothalamic hamartomas.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adolescent; Adult; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolep | 2005 |